Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMT-101 in Chronic Antibiotic-resistant Pouchitis
NCT04741087Phase 2Completed
- Sponsor
- Applied Molecular Transport
- Start
- Feb 2021
- Primary completion
- Mar 2022
- Modality
- Fc-Fusion Proteins
- Countries
- 10
01
Overview
A Phase 2 trial of AMT-101 in pouchitis, sponsored by Applied Molecular Transport. Started Feb 2021; status: completed.
02
Drugs
AMT-101
03
Conditions
pouchitis
Beyond the preview
Go deeper on NCT04741087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04741087.